Health Care & Life Sciences » Pharmaceuticals | Ahn-Gook Pharmaceutical Co. Ltd.

Ahn-Gook Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
154,100
167,936
197,736
174,002
183,600
Cost of Goods Sold (COGS) incl. D&A
68,190
77,382
101,339
88,798
79,229
Gross Income
85,910
90,555
96,396
85,204
104,370
SG&A Expense
75,219
80,168
83,037
81,012
93,639
EBIT
10,275
9,968
12,934
3,918
10,439
Unusual Expense
164
512
1,402
22
27
Non Operating Income/Expense
1,596
2,239
55
1,770
2,082
Interest Expense
857
525
630
885
822
Pretax Income
8,218
7,046
11,314
1,562
12,532
Income Tax
1,201
7,987
2,726
228
4,340
Equity in Affiliates
70
71
309
1
-
Consolidated Net Income
6,947
870
8,897
1,333
8,192
Net Income
6,525
801
9,364
1,715
8,159
Net Income After Extraordinaries
6,525
233
9,364
1,715
8,159
Net Income Available to Common
6,525
850
9,364
1,715
8,159
EPS (Basic)
629.70
121.00
818.00
150.00
712.00
Basic Shares Outstanding
10
11
11
11
11
EPS (Diluted)
625.98
120.69
812.05
162.72
711.12
Diluted Shares Outstanding
10
11
12
12
12
EBITDA
12,432
12,763
15,800
7,083
13,779
Other Operating Expense
415
419
426
274
293
Non-Operating Interest Income
233
355
358
321
365
Minority Interest Expense
422
69
467
382
33
Equity in Affiliates (Pretax)
-
-
-
-
441

About Ahn-Gook Pharmaceutical Co.

View Profile
Address
613 Siheung-daero
Seoul SL 07445
Korea, Republic Of
Employees -
Website http://ahn-gook.com
Updated 09/14/2018
Ahn-Gook Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. Its products include health function food, medical supplement, quasi-drugs, over-the-counter drugs, ethical drugs, elatin solution and tablet, losastar tablet, suprafen tablet, and recommended products such as tobicom-S soft capsule, levotension tablet, and tobicomKid Q-10 chewable tablet. The company was founded by Noh Jong-Hyeong on September 16, 1955 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.